BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

529 related articles for article (PubMed ID: 15380141)

  • 1. The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology.
    Balen A
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):685-706. PubMed ID: 15380141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome.
    Baskind NE; Balen AH
    Best Pract Res Clin Obstet Gynaecol; 2016 Nov; 37():80-97. PubMed ID: 27137106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
    Blank SK; McCartney CR; Helm KD; Marshall JC
    Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.
    Nardo LG; Patchava S; Laing I
    Panminerva Med; 2008 Dec; 50(4):267-78. PubMed ID: 19078868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome.
    Blank SK; McCartney CR; Marshall JC
    Hum Reprod Update; 2006; 12(4):351-61. PubMed ID: 16670102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance, hypersecretion of LH, and a dual-defect hypothesis for the pathogenesis of polycystic ovary syndrome.
    Poretsky L; Piper B
    Obstet Gynecol; 1994 Oct; 84(4):613-21. PubMed ID: 8090402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of polycystic ovary syndrome: involvement of genetic and environmental factors.
    Franks S; McCarthy MI; Hardy K
    Int J Androl; 2006 Feb; 29(1):278-85; discussion 286-90. PubMed ID: 16390494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polycystic ovarian disease. 1. The current data on its etiology and pathogenesis].
    Rachev E
    Akush Ginekol (Sofiia); 1999; 38(2):42-5. PubMed ID: 10730388
    [No Abstract]   [Full Text] [Related]  

  • 9. PCOS: an ovarian disorder that leads to dysregulation in the hypothalamic-pituitary-adrenal axis?
    Doi SA; Towers PA; Scott CJ; Al-Shoumer KA
    Eur J Obstet Gynecol Reprod Biol; 2005 Jan; 118(1):4-16. PubMed ID: 15596265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Functional states of pituitary-ovary, adrenal and thyroid axes in women with polycystic ovarian syndrome].
    Wu X; Zhang Z; Su Y
    Zhonghua Fu Chan Ke Za Zhi; 1998 Mar; 33(3):153-6. PubMed ID: 10682483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pathogenesis of infertility and early pregnancy loss in polycystic ovary syndrome.
    van der Spuy ZM; Dyer SJ
    Best Pract Res Clin Obstet Gynaecol; 2004 Oct; 18(5):755-71. PubMed ID: 15380145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polycystic ovary syndrome in adolescent girls.
    Baldauff NH; Witchel SF
    Curr Opin Endocrinol Diabetes Obes; 2017 Feb; 24(1):56-66. PubMed ID: 27906711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roles of Hypothalamic-Pituitary-Adrenal Axis and Hypothalamus-Pituitary-Ovary Axis in the Abnormal Endocrine Functions in Patients with Polycystic Ovary Syndrome.
    Wang F; Zhang ZH; Xiao KZ; Wang ZC
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Oct; 39(5):699-704. PubMed ID: 29125115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?
    Berga SL; Daniels TL
    Semin Reprod Endocrinol; 1997 May; 15(2):169-75. PubMed ID: 9165660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothesis: aberrant puberty and the Stein-Leventhal syndrome.
    Mechanick JI; Futterweit W
    Int J Fertil; 1984; 29(1):35-8. PubMed ID: 6146582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome.
    Barontini M; García-Rudaz MC; Veldhuis JD
    Arch Med Res; 2001; 32(6):544-52. PubMed ID: 11750729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome in adolescence.
    Blank SK; Helm KD; McCartney CR; Marshall JC
    Ann N Y Acad Sci; 2008; 1135():76-84. PubMed ID: 18574211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathophysiology of ovarian steroid secretion in polycystic ovary syndrome.
    Barnes RB
    Semin Reprod Endocrinol; 1997 May; 15(2):159-68. PubMed ID: 9165659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.